These authors also demonstrated that MSCs have an elevated threshold for CIS-induced apoptosis, which was characterized by a lack of caspase-9 activity in apoptotic cells and an increased p53 expression, independent of apoptosis induction (Mueller et al., 2006). The gene discussed is TP53; the disease is in situ carcinoma.